Skip to main content
. Author manuscript; available in PMC: 2014 Mar 11.
Published in final edited form as: Biomacromolecules. 2013 Feb 27;14(3):920–929. doi: 10.1021/bm301999c

Figure 1.

Figure 1

(a) Synthetic scheme of Phe-OCA monomer and the structure of (BDI-EI)ZnN(TMS)2 catalyst. (b) Schematic illustration of (BDI-EI)ZnN(TMS)2/Cpt mediated ring-opening polymerization (ROP) of Phe-OCA followed by formulation of Cpt-PheLAn nanoconjugates (NCs, n = the feed ratio of Phe-OCA/Cpt) using nanoprecipitation. (c) Chemical structures of hydroxyl-containing paclitaxel, doxorubicin and docetaxel.